We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Amazon, Tesla, NextEra Energy, CME Group and Boston Scientific
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 17, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amazon.com, Inc. (AMZN - Free Report) , Tesla, Inc. (TSLA - Free Report) , NextEra Energy, Inc. (NEE - Free Report) , CME Group Inc. (CME - Free Report) and Boston Scientific Corporation (BSX - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for Amazon, Tesla and NextEra
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Amazon.com, Tesla, and NextEra Energy. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Amazon have moved sideways to down since September last year, as the market became increasingly skeptical about the company's standing in the post-Covid world. As a result, the stock has lagged the broader market over the past year - up +32.4% vs. +46.5% for the S&P 500 index.
In addition to the company's ecommerce dominance, solid Prime momentum owing to ultrafast delivery services and expanding content portfolio is a key catalyst for growth. However, rising cloud competition from Microsoft and Google poses risk. Further, growing transportation costs are a matter of concern.
Tesla shares have lost ground lately, as sentiment has turned against 'growth' companies in a backdrop of inflation worries, but the stock has otherwise been a stellar performer (up +42.7% over the last six months against the Zacks Domestic Automotive industry's gain of +29.6%). The Zacks analyst believes that the company has a first-mover advantage in the e-mobility space, with high range vehicles, superior technology and software edge.
Robust Model 3/Y demand, Shanghai Gigafactory prospects, amazing line-up of upcoming products and aggressive expansion efforts bode well for the firm. However, the firm's high operating costs and massive capex owing to heavy investments related to the construction of gigafactories might strain near-term financials. Waning margins for Model S/X, chip crunch and lofty valuation of the firm are other concerns.
Shares of NextEra have lost -12.2% in the past three months against the Zacks Electric Power industry's gain of +3.4%. The Zacks analyst believes that NextEra Energy is likely to benefit from its well-chalked out $50-$55 billion capital investment plan to strengthen infrastructure and add more clean assets to the generation portfolio.
Meanwhile, the company has ample liquidity to meet the current debt obligations. However, its nature of business is subject to complex and comprehensive federal, state, as well as other regulations. If the planned nuclear plant outages last longer, the company's operations and profitability might be hampered.
Other noteworthy reports we are featuring today include CME Group and Boston Scientific.
Time to Invest in Legal Marijuana
If you're looking for big gains, there couldn't be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%
You're invited to check out Zacks' Marijuana Moneymakers: An Investor's Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Amazon, Tesla, NextEra Energy, CME Group and Boston Scientific
For Immediate Release
Chicago, IL – May 17, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amazon.com, Inc. (AMZN - Free Report) , Tesla, Inc. (TSLA - Free Report) , NextEra Energy, Inc. (NEE - Free Report) , CME Group Inc. (CME - Free Report) and Boston Scientific Corporation (BSX - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for Amazon, Tesla and NextEra
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Amazon.com, Tesla, and NextEra Energy. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of Amazon have moved sideways to down since September last year, as the market became increasingly skeptical about the company's standing in the post-Covid world. As a result, the stock has lagged the broader market over the past year - up +32.4% vs. +46.5% for the S&P 500 index.
In addition to the company's ecommerce dominance, solid Prime momentum owing to ultrafast delivery services and expanding content portfolio is a key catalyst for growth. However, rising cloud competition from Microsoft and Google poses risk. Further, growing transportation costs are a matter of concern.
(You can read the full research report on Amazon here >>>)
Tesla shares have lost ground lately, as sentiment has turned against 'growth' companies in a backdrop of inflation worries, but the stock has otherwise been a stellar performer (up +42.7% over the last six months against the Zacks Domestic Automotive industry's gain of +29.6%). The Zacks analyst believes that the company has a first-mover advantage in the e-mobility space, with high range vehicles, superior technology and software edge.
Robust Model 3/Y demand, Shanghai Gigafactory prospects, amazing line-up of upcoming products and aggressive expansion efforts bode well for the firm. However, the firm's high operating costs and massive capex owing to heavy investments related to the construction of gigafactories might strain near-term financials. Waning margins for Model S/X, chip crunch and lofty valuation of the firm are other concerns.
(You can read the full research report on Tesla here >>>)
Shares of NextEra have lost -12.2% in the past three months against the Zacks Electric Power industry's gain of +3.4%. The Zacks analyst believes that NextEra Energy is likely to benefit from its well-chalked out $50-$55 billion capital investment plan to strengthen infrastructure and add more clean assets to the generation portfolio.
Meanwhile, the company has ample liquidity to meet the current debt obligations. However, its nature of business is subject to complex and comprehensive federal, state, as well as other regulations. If the planned nuclear plant outages last longer, the company's operations and profitability might be hampered.
(You can read the full research report on NextEra here >>>)
Other noteworthy reports we are featuring today include CME Group and Boston Scientific.
Time to Invest in Legal Marijuana
If you're looking for big gains, there couldn't be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%
You're invited to check out Zacks' Marijuana Moneymakers: An Investor's Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Today, Download Marijuana Moneymakers FREE >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.